2024 Q2 Form 10-K Financial Statement

#000149315224019773 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2024
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $975.0K $1.768M $3.005M
YoY Change 143.04% -57.43% -27.65%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $975.0K $1.768M $3.005M
YoY Change 143.04% -57.43% -27.65%
Operating Profit -$975.0K -$3.005M
YoY Change 143.04% -27.65%
Interest Expense $49.81K -$121.3K $401.0K
YoY Change -53.52% -64.42% -217.62%
% of Operating Profit
Other Income/Expense, Net -$69.30K -$79.88K -$707.4K
YoY Change -60.13% 1209.51% 11496.11%
Pretax Income -$1.044M -$1.969M -$3.712M
YoY Change 81.61% -54.2% -13.66%
Income Tax
% Of Pretax Income
Net Earnings -$1.044M -$1.969M -$3.712M
YoY Change 81.61% -54.2% -13.66%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.02
Diluted Earnings Per Share $0.00 -$0.01 -$0.02
COMMON SHARES
Basic Shares Outstanding 248.2M shares 211.3M shares
Diluted Shares Outstanding 224.3M shares 211.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.005M $30.15K $30.15K
YoY Change 761.04% -93.01% -93.01%
Cash & Equivalents $1.005M $30.15K
Short-Term Investments
Other Short-Term Assets $103.8K $21.62K $21.62K
YoY Change 338.26%
Inventory
Prepaid Expenses $103.8K $21.62K
Receivables
Other Receivables
Total Short-Term Assets $1.109M $51.77K $51.77K
YoY Change 689.76% -88.0% -88.0%
LONG-TERM ASSETS
Property, Plant & Equipment $40.45K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $140.4K $100.0K $100.0K
YoY Change 40.45% 0.0% 0.0%
TOTAL ASSETS
Total Short-Term Assets $1.109M $51.77K $51.77K
Total Long-Term Assets $140.4K $100.0K $100.0K
Total Assets $1.249M $151.8K $151.8K
YoY Change 419.66% -71.44% -71.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $406.0K $434.5K $434.5K
YoY Change 43.28% 22.48% 22.48%
Accrued Expenses $883.1K $1.486M $1.486M
YoY Change 433.25% 1512.44% 1512.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $260.0K
YoY Change
Total Short-Term Liabilities $1.549M $1.920M $1.920M
YoY Change 245.04% 329.7% 329.7%
LONG-TERM LIABILITIES
Long-Term Debt $2.875M $3.759M $3.759M
YoY Change -15.98% 12.09% 12.09%
Other Long-Term Liabilities $1.344M $533.0K $533.0K
YoY Change -5.64% -60.57% -60.57%
Total Long-Term Liabilities $4.219M $4.292M $4.292M
YoY Change -12.94% -8.78% -8.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.549M $1.920M $1.920M
Total Long-Term Liabilities $4.219M $4.292M $4.292M
Total Liabilities $5.768M $6.212M $6.212M
YoY Change 8.93% 20.58% 20.58%
SHAREHOLDERS EQUITY
Retained Earnings -$33.05M -$31.60M
YoY Change 16.11% 13.31%
Common Stock $247.0K $214.6K
YoY Change 18.0% 2.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.519M -$6.061M -$6.061M
YoY Change
Total Liabilities & Shareholders Equity $1.249M $151.8K $151.8K
YoY Change 419.66% -71.44% -71.44%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$1.044M -$1.969M -$3.712M
YoY Change 81.61% -54.2% -13.66%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$778.4K -$253.6K -$868.4K
YoY Change 147.4% 71.83% 488.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.753M 266.0K $467.2K
YoY Change -26.32% 29.42%
NET CHANGE
Cash From Operating Activities -$778.4K -253.6K -$868.4K
Cash From Investing Activities
Cash From Financing Activities $1.753M 266.0K $467.2K
Net Change In Cash $974.9K 12.43K -$401.2K
YoY Change -409.82% -94.18% -287.99%
FREE CASH FLOW
Cash From Operating Activities -$778.4K -$253.6K -$868.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001263364
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
usd
CY2023 COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
usd
CY2024 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2024 COPR Convertible Notes Payable Issued For Expenses
ConvertibleNotesPayableIssuedForExpenses
usd
CY2024 COPR Expenses Paid By Parent Company
ExpensesPaidByParentCompany
usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2023 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
usd
CY2024 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 COPR Stock Issued During Conversion Of Liabilities To Common Stock
StockIssuedDuringConversionOfLiabilitiesToCommonStock
usd
CY2024 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
usd
CY2024Q1 COPR Bond Liabilities Maturities In Next Twelve Months
BondLiabilitiesMaturitiesInNextTwelveMonths
usd
CY2024Q1 COPR Bond Liabilities Maturities In Year Four
BondLiabilitiesMaturitiesInYearFour
usd
CY2024Q1 COPR Bond Liabilities Maturities Thereafter
BondLiabilitiesMaturitiesThereafter
usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 COPR Deferred Tax Assets Timing Differences
DeferredTaxAssetsTimingDifferences
usd
CY2023Q1 COPR Deferred Tax Assets Timing Differences
DeferredTaxAssetsTimingDifferences
usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-01-31
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2024 dei Entity File Number
EntityFileNumber
333-108715
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
Yes
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
13340657 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
248212528 shares
CY2024 dei Auditor Firm
AuditorFirmId
6580
CY2023 dei Auditor Firm
AuditorFirmId
76
CY2024 dei Auditor Name
AuditorName
GreenGrowth CPAs
CY2024 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2024 dei Auditor Firm
AuditorFirmId
6580
CY2023 dei Auditor Name
AuditorName
Turner, Stone & Company, L.L.P.
CY2023 dei Auditor Location
AuditorLocation
Dallas, Texas
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30146 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
431374 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21624 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
51770 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
431374 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
100000 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
100000 usd
CY2024Q1 us-gaap Assets
Assets
151770 usd
CY2023Q1 us-gaap Assets
Assets
531374 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
434519 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
354763 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1115723 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
8817 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
240324 usd
CY2024 COPR Payroll And Related Expenses
PayrollAndRelatedExpenses
318561 usd
CY2023 COPR Payroll And Related Expenses
PayrollAndRelatedExpenses
963055 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
42000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
2769292 usd
CY2023 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
138214 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
4152885 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-4152885 usd
CY2023 COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
6095 usd
CY2024 COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
45266 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200458 usd
CY2024 us-gaap Interest Expense
InterestExpense
401035 usd
CY2023 us-gaap Interest Expense
InterestExpense
340948 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-707363 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-146585 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-3712047 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4299470 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24183399 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24183399 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-8294773 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4519207 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
973293 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1796000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
685166 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4299470 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4620577 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4620577 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4620577 usd
CY2024 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
309353 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
103846 usd
CY2024 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
269085 usd
CY2024 COPR Stock Issued During Period Value Preferred Stock And Warrants
StockIssuedDuringPeriodValuePreferredStockAndWarrants
265000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-3712047 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6060609 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6060609 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-3712047 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4299470 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
2043909 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
2769292 usd
CY2024 COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
261062 usd
CY2023 COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
6095 usd
CY2024 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
45266 usd
CY2023 COPR Convertible Notes Payable Issued For Expenses
ConvertibleNotesPayableIssuedForExpenses
360666 usd
CY2023 COPR Expenses Paid By Parent Company
ExpensesPaidByParentCompany
395735 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
21624 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
78757 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
281639 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
288689 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
83333 usd
CY2024 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-147560 usd
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-250136 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-868428 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-147574 usd
CY2024 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
202200 usd
CY2024 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
265000 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
361000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
467200 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
361000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-401228 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
213426 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
431374 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217948 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30146 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
431374 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
90813 usd
CY2024 COPR Stock Issued During Conversion Of Liabilities To Common Stock
StockIssuedDuringConversionOfLiabilitiesToCommonStock
269085 usd
CY2023 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
685166 usd
CY2024 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_802_eus-gaap--NatureOfOperations_zd6ZkkYVFy03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_828_zjnDQabnAM3i">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include the financial statements of Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) (referred to herein as “Idaho Copper”). Idaho Copper is hereinafter referred to as the “Company,” “we” and “us.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company consummated the transactions contemplated by the Stock Purchase Agreement dated as of January 31, 2022 (the “Purchase Agreement”), by and among the Company, Crystal Globe Limited, a company incorporated under the laws of British Virgin Islands (the “Seller”), and JHP Holdings, Inc., a Nevada corporation (the “Buyer”), pursuant to which the Buyer purchased <span id="xdx_906_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20220203__20220203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_ztHQJi7A4G01" title="Buyer purchased common stock shares">16,644,820</span> shares of common stock of the Company from the Seller.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2023, the Company entered into and consummated the transactions contemplated by a share exchange agreement (the “Share Exchange Agreement”) by and among the Company, International CuMo Mining Corporation, an Idaho corporation (“ICUMO”), and all of the shareholders of ICUMO (collectively, the “ICUMO Shareholders”). Pursuant to the terms of the Share Exchange Agreement (the “RTO”), the ICUMO Shareholders transferred all the issued and outstanding shares of common stock of ICUMO to the Company in exchange for <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230123__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zjr5DMej45Fj" title="Number of shares issued">182,240,000</span> shares of the Company’s common stock, par value $<span id="xdx_904_eus-gaap--EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_c20230123__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zgqOLbnpDHWe" title="Common stock, par value">0.001</span> per share. As a result of this share exchange (the “Exchange”), ICUMO became a wholly owned subsidiary of the Company. See Note 7. For financial reporting purposes, the acquisition of ICUMO and the change of control in connection with the acquisition represented a “reverse merger” and ICUMO is deemed to be the accounting acquirer in the transaction. ICUMO is the acquirer for financial reporting purposes, and the Company is the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the acquisition are those of ICUMO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continues to be a “smaller reporting company,” as defined under the Exchange Act of 1934, as amended (the “Exchange Act”) following the Exchange, however, as a result of the Exchange, the Company has ceased to be a “shell company” (as such term is defined in Rule 12b-2 under the Exchange Act).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ICUMO Background</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ICUMO is an exploration and development company with mineral right interests in the United States of America. ICUMO was originally incorporated under the laws of Nevada in 2005, as Mosquito Mining Corp. In 2013, the Company was moved to Idaho and the name changed to Idaho CuMo Mining Corporation. In early February 2023 the name was changed to Idaho Copper Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in the process of exploring its mineral rights interests in the United States and at the date of these consolidated financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of the Company to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral rights interests. The ability of the Company to realize its investment in resource properties is contingent upon the resolution of the uncertainties and confirmation of the Company’s title to the mineral properties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30146 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-3712047 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zpA1zwRdj6Ec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z5iCIWBJpzZb">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
3135000 usd
CY2024Q1 COPR Bond Liabilities Maturities In Year Two
BondLiabilitiesMaturitiesInYearTwo
1546000 usd
CY2024Q1 COPR Bond Liabilities Maturities In Year Three
BondLiabilitiesMaturitiesInYearThree
500000 usd
CY2024Q1 COPR Bond Liabilities Maturities In Year Five
BondLiabilitiesMaturitiesInYearFive
1089000 usd
CY2024Q1 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
3135000 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
23 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
23 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
79585 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214647732 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
214647732 shares
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
22646000 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
11323000 shares
CY2023Q1 us-gaap Share Price
SharePrice
0.125
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2027-12-31
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1324731 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2024Q1 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
757000 usd
CY2024Q1 us-gaap Share Price
SharePrice
0.22
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.13
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.1110 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.6518 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0388 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
The remaining vesting milestones required to be met are (1) obtaining an updated PEA, (2) an uplist of the Company’s common stock to a national exchange and (3) the successful raising of $5 million or more in new capital. Each of these milestones vest an additional 20% of the options upon being met and were estimated to have a 50% probability of being met as of January 31, 2024. Management reviews the estimate of meeting each probability as well as the related timing at each reporting period
CY2023Q3 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
216000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
216000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
216000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
216000 usd
CY2023Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y
CY2023Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y
CY2023Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y
CY2024Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y
CY2023Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
112867 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
112867 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
112867 usd
CY2024Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
112867 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
751916 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
397846 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.05 pure
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-285980 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-321337 usd
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-68090 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-76509 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
354070 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
397846 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
751916 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
397846 usd
CY2024Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
751916 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
397846 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
751916 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
397846 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
751916 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
397846 usd

Files In Submission

Name View Source Status
0001493152-24-019773-index-headers.html Edgar Link pending
form10-k_004.jpg Edgar Link pending
0001493152-24-019773-index.html Edgar Link pending
0001493152-24-019773.txt Edgar Link pending
0001493152-24-019773-xbrl.zip Edgar Link pending
audit_001.jpg Edgar Link pending
audit_002.jpg Edgar Link pending
audit_01.jpg Edgar Link pending
aud_001.jpg Edgar Link pending
copr-20240131.xsd Edgar Link pending
ex10-10.htm Edgar Link pending
ex10-10_001.jpg Edgar Link pending
ex10-10_002.jpg Edgar Link pending
ex10-10_003.jpg Edgar Link pending
ex10-10_004.jpg Edgar Link pending
ex10-10_005.jpg Edgar Link pending
ex10-10_006.jpg Edgar Link pending
ex10-11.htm Edgar Link pending
ex10-11_001.jpg Edgar Link pending
ex10-11_002.jpg Edgar Link pending
ex10-11_003.jpg Edgar Link pending
ex10-11_004.jpg Edgar Link pending
ex10-11_005.jpg Edgar Link pending
ex10-11_006.jpg Edgar Link pending
ex10-12.htm Edgar Link pending
ex10-12_001.jpg Edgar Link pending
ex10-12_002.jpg Edgar Link pending
ex10-12_003.jpg Edgar Link pending
ex10-12_004.jpg Edgar Link pending
ex10-12_005.jpg Edgar Link pending
ex10-12_006.jpg Edgar Link pending
ex10-12_007.jpg Edgar Link pending
ex10-13.htm Edgar Link pending
ex10-13_001.jpg Edgar Link pending
ex10-13_002.jpg Edgar Link pending
ex10-13_003.jpg Edgar Link pending
ex10-13_004.jpg Edgar Link pending
ex10-13_005.jpg Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
form10-k_003.jpg Edgar Link pending
copr-20240131_cal.xml Edgar Link unprocessable
copr-20240131_lab.xml Edgar Link unprocessable
copr-20240131_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_005.jpg Edgar Link pending
form10-k_006.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
copr-20240131_def.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed